Sanderling Ventures Investments & Fund Profile

Overview

Investment firm specializing in seed and early-stage biomedical ventures.

Founded

1979

Deals · 12mo

0

Links

Website LinkedIn

Stage focus

Series B

Series C

Series D

Geographic focus

Canada

United States

Sector focus

Finance

Financial Services

Venture Capital

Investment portfolio

30rounds

LedParticipated

NAME	DATE	SIZE
Glycomine	Apr 2025Participated	$115 MSeries C
Glycomine	Jun 2021Participated	$68 MSeries B
ViaCyte	Jun 2021Participated	$45 MSeries D
CalciMedica	Mar 2021Participated	$21 MSeries D
ViaCyte	May 2020Participated	$27 MSeries D
CalciMedica	May 2020Participated	$15 MSeries C
Glycomine	Aug 2019Participated	$33 MSeries B
ViaCyte	Nov 2018Participated	$80 MSeries D
Metavention	Jan 2018Participated	$65 MSeries C
PreciThera	Jul 2017Participated	$29 MSeries A
Glycomine	Nov 2016Led	$12 MSeries A
Torax Medical	Aug 2016Participated	$25 MSeries E
Glycomine	Apr 2025Participated	$115 MSeries C
Glycomine	Jun 2021Participated	$68 MSeries B
ViaCyte	Jun 2021Participated	$45 MSeries D
CalciMedica	Mar 2021Participated	$21 MSeries D
ViaCyte	May 2020Participated	$27 MSeries D
CalciMedica	May 2020Participated	$15 MSeries C
Glycomine	Aug 2019Participated	$33 MSeries B
ViaCyte	Nov 2018Participated	$80 MSeries D
Metavention	Jan 2018Participated	$65 MSeries C
PreciThera	Jul 2017Participated	$29 MSeries A
Glycomine	Nov 2016Led	$12 MSeries A
Torax Medical	Aug 2016Participated	$25 MSeries E

30 Items

30

Items

...

Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Sanderling Ventures: 30 funding rounds are recorded in the selected participation categories. All available history
Round type	Led deals	Participated deals
Series A	1	1
Series B	1	4
Series C+	3	13
Other Equity	1	6

Monthly Deal Activity

Sanderling Ventures: 30 deals are recorded across 232 months. All available history
Month	Deals
Jul '07	2
Aug '07	0
Sep '07	0
Oct '07	0
Nov '07	0
Dec '07	1
Jan '08	0
Feb '08	0
Mar '08	0
Apr '08	0
May '08	0
Jun '08	0
Jul '08	0
Aug '08	0
Sep '08	0
Oct '08	0
Nov '08	0
Dec '08	0
Jan '09	0
Feb '09	0
Mar '09	0
Apr '09	0
May '09	0
Jun '09	0
Jul '09	0
Aug '09	0
Sep '09	0
Oct '09	0
Nov '09	0
Dec '09	0
Jan '10	1
Feb '10	0
Mar '10	0
Apr '10	2
May '10	0
Jun '10	0
Jul '10	0
Aug '10	2
Sep '10	1
Oct '10	1
Nov '10	0
Dec '10	0
Jan '11	1
Feb '11	1
Mar '11	0
Apr '11	0
May '11	0
Jun '11	0
Jul '11	0
Aug '11	0
Sep '11	0
Oct '11	0
Nov '11	0
Dec '11	1
Jan '12	0
Feb '12	0
Mar '12	0
Apr '12	0
May '12	0
Jun '12	0
Jul '12	0
Aug '12	0
Sep '12	1
Oct '12	0
Nov '12	0
Dec '12	0
Jan '13	0
Feb '13	1
Mar '13	0
Apr '13	0
May '13	0
Jun '13	0
Jul '13	0
Aug '13	0
Sep '13	0
Oct '13	0
Nov '13	0
Dec '13	1
Jan '14	0
Feb '14	0
Mar '14	0
Apr '14	0
May '14	0
Jun '14	0
Jul '14	0
Aug '14	0
Sep '14	0
Oct '14	0
Nov '14	0
Dec '14	0
Jan '15	0
Feb '15	1
Mar '15	0
Apr '15	0
May '15	0
Jun '15	0
Jul '15	0
Aug '15	0
Sep '15	0
Oct '15	0
Nov '15	0
Dec '15	0
Jan '16	0
Feb '16	0
Mar '16	0
Apr '16	1
May '16	0
Jun '16	0
Jul '16	0
Aug '16	1
Sep '16	0
Oct '16	0
Nov '16	1
Dec '16	0
Jan '17	0
Feb '17	0
Mar '17	0
Apr '17	0
May '17	0
Jun '17	0
Jul '17	1
Aug '17	0
Sep '17	0
Oct '17	0
Nov '17	0
Dec '17	0
Jan '18	1
Feb '18	0
Mar '18	0
Apr '18	0
May '18	0
Jun '18	0
Jul '18	0
Aug '18	0
Sep '18	0
Oct '18	0
Nov '18	1
Dec '18	0
Jan '19	0
Feb '19	0
Mar '19	0
Apr '19	0
May '19	0
Jun '19	0
Jul '19	0
Aug '19	1
Sep '19	0
Oct '19	0
Nov '19	0
Dec '19	0
Jan '20	0
Feb '20	0
Mar '20	0
Apr '20	0
May '20	2
Jun '20	0
Jul '20	0
Aug '20	0
Sep '20	0
Oct '20	0
Nov '20	0
Dec '20	0
Jan '21	0
Feb '21	0
Mar '21	1
Apr '21	0
May '21	0
Jun '21	2
Jul '21	0
Aug '21	0
Sep '21	0
Oct '21	0
Nov '21	0
Dec '21	0
Jan '22	0
Feb '22	0
Mar '22	0
Apr '22	0
May '22	0
Jun '22	0
Jul '22	0
Aug '22	0
Sep '22	0
Oct '22	0
Nov '22	0
Dec '22	0
Jan '23	0
Feb '23	0
Mar '23	0
Apr '23	0
May '23	0
Jun '23	0
Jul '23	0
Aug '23	0
Sep '23	0
Oct '23	0
Nov '23	0
Dec '23	0
Jan '24	0
Feb '24	0
Mar '24	0
Apr '24	0
May '24	0
Jun '24	0
Jul '24	0
Aug '24	0
Sep '24	0
Oct '24	0
Nov '24	0
Dec '24	0
Jan '25	0
Feb '25	0
Mar '25	0
Apr '25	1
May '25	0
Jun '25	0
Jul '25	0
Aug '25	0
Sep '25	0
Oct '25	0
Nov '25	0
Dec '25	0
Jan '26	0
Feb '26	0
Mar '26	0
Apr '26	0
May '26	0
Jun '26	0
Jul '26	0
Aug '26	0
Sep '26	0
Oct '26	0

Sector Breakdown

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Sanderling Ventures: Health & Life Sciences is the largest displayed sector by deal count (30 deals). All available history
Sector	Deals
Health & Life Sciences	30
Manufacturing	1

Deal Size Distribution

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Sanderling Ventures: 30 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)	Deals
<$5M	1
$5M-$10M	3
$10M-$25M	12
$25M-$50M	9
$50M-$100M	3
$100M-$250M	2
$250M-$500M	0
$500M-$1B	0
$1B+	0

Deals By Geography

Top 2 of 2 regions; European countries are grouped as Europe.

Sanderling Ventures: United States has the largest recorded deal count among the displayed regions (26 deals). All available history
Region	Deals
United States	26
Canada	4

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Sanderling Ventures: 20 co-investors are shown, with Mesa Verde Venture Partners sharing 5 recorded deals. All available history
Co-investor	Shared deals
Mesa Verde Venture Partners	5
Chiesi Ventures	4
Signal Peak Ventures	4
Bain Capital Life Sciences	3
CTI Life Sciences Fund	3
Intel Capital	3
Novo Holdings	3
PrairieGold Venture Partners	3
RA Capital Management	3
TPG	3
Abingworth	2
Accuitive Medical Ventures	2
Alta Partners	2
Archipel Capital	2
Asahi Kasei Pharma	2
Asset Management	2
Caxton Advantage Life Sciences Fund	2
Cerner Capital	2
Clarus Ventures	2
EDBI	2